CircNova

CircNova

Private
Detroit, MichiganHealthcare & Life Scienceshttps://www.circnova.com/

Last Round

Seed

Feb 21, 2025

Total Funding Raised

$4.3M

Momentum Score

25 /100

Company Overview

CircNova, Inc. is a biotechnology company founded in 2023 that operates at the intersection of artificial intelligence and genetic medicine. The company has developed a proprietary AI platform, NovaEngine™, which is used to generate, analyze, and identify circular RNA (circRNA) for therapeutic development. This technology aims to address previously "undruggable" diseases, including triple-negative breast cancer, ovarian cancer, and neurodegenerative diseases. CircNova's business model involves developing its own portfolio of circRNA therapeutics and partnering with other biopharmaceutical companies to co-develop novel treatments or license its platform. The company is headquartered in Detroit, Michigan, and secured $3.3 million in a seed funding round in early 2025.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

circular RNA therapeuticscircRNAAI drug discoverygenerative biologyin silico drug discoveryRNA therapeuticscomputational biologyRNA structure predictionundruggable targetsgenerative AItherapeutic co-developmentbiopharma partnershipsoncologyneurodegenerative diseasesrare genetic diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CircNova Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CircNova Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 21, 2025
GrantMay 23, 2024
Pre SeedJan 28, 2024

Key People

Founding team and executive leadership

Steve Schwartz

CTO, Co-founder

Founding Team

CircNova Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors grew 32% MoM.

  • Feb 21, 2025

    Raised $3.3M in a seed funding round.

CircNova Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CircNova Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CircNova's valuation, stock price, and market status.

Firmographic Details

HeadquartersDetroit, Michigan
Employee Range12
Year Founded2023
Last FundingFeb 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.